<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 12b-25
Commission File Number: 0-21595
NOTIFICATION OF LATE FILING OF FORM 10-Q
For Period Ended: March 31, 2000
Part 1. Registrant Information
ENAMELON, INC.
--------------
(Full name of registrant)
7 Cedar Brook Drive, Cranbury, NJ 08512
---------------------------------------
(Address of Principal executive office)
Part II. Rule 12b-25 (b) and (c)
If the subject report could not be filed without unreasonable effort or
expense, and the registrant seeks relief pursuant to Rule 12b-25(b), the
following should be completed. (Check appropriate box.)
[x] (a) The reasons described in reasonable detail in Part III of this form
could not be eliminated without unreasonable effort or expense;
[x] (b) The subject quarterly report on Form 10-Q will be filed on or before
the 15th calendar day following the prescribed due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule 12b-25(c)
has been attached if applicable.
Part III. Narrative
As the Company's Chief Financial Officer and Controller have resigned and
have not yet been replaced, the Company needs more time to properly complete its
Form 10-Q for the fiscal quarter ended March 31, 2000.
Part IV. Other Information
(1) Name and telephone number of person to contact in regard to this
notification:
Dr. Steven R. Fox (609) 395-6900
----------------- -------------
(Name) (Telephone number)
(2) Have all other periodic reports required under Section 13 or 15(d) of
the Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
[x] Yes [ ] No
(3) Is it anticipated that any significant change in results of operations
from the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or portion thereof?
[ ] Yes [x] No
<PAGE>
If so: attach an explanation of the anticipated change, both narratively
and quantitatively, and, if appropriate, state the reasons why a reasonable
estimate of the results cannot be made.
ENAMELON, INC.
--------------
(Name of registrant as specified in charter)
Has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: May 15, 2000 By: /s/ Dr. Steven R. Fox
-----------------------------
Name: Dr. Steven R. Fox
Title: Chairman of the Board of Directors
Chief Executive Officer
Instruction. The form may be signed by an executive officer of the
registrant or by any other duly authorized representative. The name and
title of the person signing the form shall be typed and printed beneath
the signature. If the statement is signed on behalf of the registrant by
an authorized representative (other than an executive officer), evidence
of the representative's authority to sign on behalf of the registrant
shall be filed with the form.
ATTENTION:
Intentional misstatements or omissions of fact constitute Federal criminal
violations (see 18 U.S.C. 1001).
